SACRAMENTO, Calif. - TelAve -- HuMOLYTE, a medical food designed to support patients undergoing chemotherapy, today announced the launch of its Patient Experience Survey, aimed at gathering real-world feedback from individuals preparing to begin chemotherapy. This initiative offers selected participants access to HuMOLYTE at no cost in exchange for their experience and insights.

HuMOLYTE is GRAS (Generally Recognized as Safe) and formulated to help alleviate common chemotherapy-related side effects, including vomiting, diarrhea, and mouth sores, by supporting hydration, electrolyte balance, and mucosal health. In addition to ongoing formal clinical trials, the Patient Experience Survey will help the HuMOLYTE team better understand patient needs and refine product use.

"While clinical data is critical, patient voices are equally valuable in helping us improve HuMOLYTE and better serve the oncology community," said Dr. Sourabh Kharait, CEO at IGH Naturals, "This survey allows us to collect feedback from individuals actively going through chemotherapy and ensure we're addressing real-world challenges."

More on TelAve News

• $1B Target by 2027 Amid eSIM, Global Roaming Expansion; $57.6M Q1 Revenue and Market Uplisting, Advancing Toward IQSTEL, Inc. (Stock Symbol: IQST)
• LIB TH-50/TH-80 Benchtop Environmental Chamber Drives Global Demand
• Marc Soucy's Newest Music Series Approaches Its One Year Mark
• Fairmint Releases Whitepaper for Open Captable Protocol (OCP) to Advance On-Chain Equity Securities
• Award-winning NJ Author Celebrates New Release and Multi-Author Collaboration

Survey Participation Details:

• Eligibility: Individuals preparing to start chemotherapy.
• What's Provided: Selected participants will receive HuMOLYTE at no cost for one chemotherapy cycle.
• Expectation: Follow the recommended protocol and complete a brief post-treatment survey.
• Purpose: Feedback will be used for product development and quality improvement.

HuMOLYTE is developed for use under physician supervision and is not intended to diagnose, treat, cure, or prevent any disease.

About HuMOLYTE

HuMOLYTE is a medical food specifically formulated to support individuals undergoing chemotherapy by promoting hydration, electrolyte balance, and mucosal health. Backed by scientific research and developed to address common gastrointestinal side effects, HuMOLYTE is currently undergoing human clinical trials.

Apply for the Survey

Interested individuals can learn more and apply for the Patient Experience Survey at:

https://www.humolyte.com/blog/join-the-humolyte-chemotherapy-patient-experience-survey-apply-for-a-free-supply